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Abstract
Background: More than a third of the world’s children are infected with intestinal nematodes. Current control approaches
emphasise treatment of school age children, and there is a lack of information on the effects of deworming preschool
children.
Methodology: We studied the effects on the heights and weights of 3,935 children, initially 1 to 5 years of age, of five
rounds of anthelmintic treatment (400 mg albendazole) administered every 6 months over 2 years. The children lived in 50
areas, each defined by precise government boundaries as urban slums, in Lucknow, North India. All children were offered
vitamin A every 6 months, and children in 25 randomly assigned slum areas also received 6-monthly albendazole.
Treatments were delivered by the State Integrated Child Development Scheme (ICDS), and height and weight were
monitored at baseline and every 6 months for 24 months (trial registration number NCT00396500). p Value calculations are
based only on the 50 area-specific mean values, as randomization was by area.
Findings: The ICDS infrastructure proved able to deliver the interventions. 95% (3,712/3,912) of those alive at the end of the
study had received all five interventions and had been measured during all four follow-up surveys, and 99% (3,855/3,912)
were measured at the last of these surveys. At this final follow up, the albendazole-treated arm exhibited a similar height
gain but a 35 (SE 5) % greater weight gain, equivalent to an extra 1 (SE 0.15) kg over 2 years (99% CI 0.6–1.4 kg, p=10
211).
Conclusions: In such urban slums in the 1990s, five 6-monthly rounds of single dose anthelmintic treatment of
malnourished, poor children initially aged 1–5 years results in substantial weight gain. The ICDS system could provide a
sustainable, inexpensive approach to the delivery of anthelmintics or micronutrient supplements to such populations. As,
however, we do not know the control parasite burden, these results are difficult to generalize.
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Introduction
Intestinal nematodes are amongst the most common agents of
chronic infection in low income countries [1]. In India, it has been
reported that about half the population is infected with round
worm (Ascaris lumbricoides), whipworm (Trichuris trichiura) and/or
hookworm (Necator americanus, Ancylostoma duodenale) [2]. These
infections could have significant effects on the development of
children [3]. Any effects on physical development would typically
be subtle and chronic, manifesting as longstanding anaemia [4–6],
reduced physical fitness [7], and somewhat constrained growth
[8]. There might also be subtle, but important developmental
effects on cognition and educational achievement [9–11].
Recognition of these potential consequences of infection has led
to increasing emphasis on community-based anthelmintic treat-
ment to reduce worm burdens in children irrespective of direct
evidence of infection, particularly children of school age
[1,3,12,13].
The current focus on schoolchildren reflects three factors: the
evidence of an effect on weight and cognition in this age group; the
accessibility of school children to treatment delivered through the
education infrastructure; and the epidemiological observation that
school children tend to harbour the largest worm burdens [12].
Few studies have examined the impact of infection on younger
children, partly because the burden of worms and, it has been
assumed, disease is light at this early age, and perhaps because of
www.plosntds.org 1 April 2008 | Volume 2 | Issue 4 | e223the practical difficulty in reaching the pre-school population. Two
recent studies from Africa, however, suggest different conclusions.
A study of deworming children during home visits in rural
Zanzibar indicated that the youngest children, who are most at
risk of growth retardation, showed the greatest increase in growth
rate after treatment with anthelmintics [4], while a study of
deworming pre-school children during ‘‘health days’’ in Uganda
increased growth rate and was cost-effective [14].
The situation in North India suggested that deworming of
children younger than school age might be beneficial and
practical. In Uttar Pradesh (U.P.) in North India, high levels of
worm infection and malnutrition have been observed in pre-school
children [15] and our observations indicate that more than a third
of pre-school children around Lucknow are infected, predomi-
nantly with Ascaris lumbricoides. A study of supplementary nutrition
suggested some benefit from deworming such children [16].
Furthermore, the State Integrated Child Development Scheme
(ICDS) provides a health care infrastructure that aims to reach all
children up to 5 or 6 years of age, and thus provides a potentially
cost effective mechanism for delivering anthelmintics to these
children [17].
This was a cluster-randomized trial, since for a study on this
scale randomization by area was the only feasible strategy. The
study was conducted using the existing community and health
infrastructures to allow the possibility that the interventions could
be institutionalised and scaled up with minimum additional inputs.
Methods
We conducted an open-labelled, cluster-randomized trial within
the ICDS infrastructure in urban Lucknow UP with the
hypotheses that the ICDS could deliver anthelmintics regularly
to pre-school children in the urban slums of Lucknow, and that if
they did then this would result in a growth benefit (trial registration
number NCT00396500). We obtained approval from the
institutional human ethics committee in Lucknow. The primary
objective was to assess the impact of 6 monthly deworming on
weight and height gain over 2 years in children initially aged 1 to
5 years of age. The protocol for this trial and supporting
CONSORT checklist are available as Supporting Information;
see Protocol S1 and Checklist S1.
There are 203 designated urban slum areas in urban Lucknow,
each of which has about 100 pre-school children and is served by a
pre-school centre, known as an anganwadi (=courtyard) center.
An ICDS worker in each area uses the anganwadi center to
provide general care to children under 5, including administration
of 100,000 units of vitamin A syrup every 6 months. A
geographically convenient group of fifty of these slum areas was
chosen for the study. All these areas continued their vitamin A
supplementation and other usual care during the study period, and
25 were randomly allocated to offer in addition, 400 mg of
albendazole (Zentel, SmithKline Beecham) as 10 ml suspension at
the same time as the six-monthly vitamin A.
The ICDS workers were provided training regarding: (a)
indications of the interventions, precautions during the storage
and administration of the interventions, and adverse effects; (b)
strategies for community mobilization; (c) record keeping; and (d)
procedures for weight and height measurement. Interventions
were administered orally in the anganwadi centers by the visiting
research team working in collaboration with the local anganwadi
center staff. All resident children between 1 and 5 years of age
were recruited to the study, and all parents of eligible children
provided written consent. None of the parents refused participa-
tion, because when, after much discussion, those in such
communities chose to cooperate they all became willing to do so
for the common good. A research team was trained to measure
height to the nearest 0.1 cm, using a stadiometer, and weight to
the nearest 0.1 kg, using electronic weighing scales which were
calibrated daily. Anthropometry of each child was done at
baseline, and then at 6-month intervals for 24 months. Adverse
events were not assessed in this trial.
Sample size
It was expected from cross-sectional surveys that the 2-year
weight gain in this poorly nourished population would be only
about 3 kg, perhaps with standard deviation (SD) about 1 or
1.5 kg. Exact sample size calculations were not possible because it
was not known what fraction f of this variance was due to real
differences between different slums. If 25 albendazole and 25
control slum areas are compared, with about 100 children per
slum area, then unless f is very small, the standard error of the
treatment effect (SE) is approximately 0:4
ﬃﬃ
f
p
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SE~SD:
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p
; f is some-
times called the intra-cluster correlation coefficient, or ICC). If, for
example, f=1/4 then SE would be about 0.2 kg, so the study
would have a reasonable chance of detecting a 2-year weight gain
of 0.5 kg.
ICCs for future reference were estimated as the fractional
reduction on comparing the residual mean squares after regression
on initial age, sex and cluster membership with those after
regression only on initial age, sex and treatment allocation.
Random allocation was done by SA, listing the anganwadi
centers of each slum area serially in alphabetical order, numbering
them from 1 to 50, and then generating a single random number
by computer that allocated either all odd or all even numbers to a
specific intervention type.
Analysis
EPI 6.1 statistical software was used to calculate the weight-for-
age, height-for-age and weight-for-height z-scores, which compare
the study children to the nutritional standards of the World Health
Organization. The z-score measures show, in standard deviations,
how far a particular measurement departs from thesestandards.The
Author Summary
About one-third of children in poor communities globally
are infected with intestinal worms. Treatment is effective
and safe, and involves taking a pill once or twice a year.
Most deworming programs are aimed at children of school
age because most infections occur in this age group and
schoolchildren are easy to reach and treat in schools. But
preschool children are also infected and, in North India, the
State Integrated Child Development Scheme (ICDS)
provides a system of preschools and teachers that could
potentially deliver treatment to younger children. To see
whether deworming would be feasible and beneficial for
preschool children, we studied its effects on the growth of
4,000 children initially aged 1 to 5 years in the urban slums
of Lucknow, North India. Over a 2-year period, the ICDS
successfully provided regular 6-monthly treatment to 95%
of the children targeted, and the treated children gained
about an extra kilogram in weight when compared to
untreated children in neighbouring slums. These results
show that the preschool program in India could provide
regular deworming simply and cheaply, and suggest that
poor and malnourished preschool children with a heavy
worm load could show a substantial gain in weight as a
result.
Deworming Children in India
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stunting (height-for-age z-score#22) andwasting(weight-for-height
z-score #22 ) were calculated for all the enrolled children.
Because randomization was by area, we first assessed the area-
specific results, one per area. We then compared these 50 numbers
with each other (25 versus 25), and our means and standard errors
reflect the variation between these 50 values. For example, height
and weight gain in one year and at two years were compared in 25
‘‘usual care’’ versus 25 ‘‘usual care plus albendazole’’ areas.
Reported here are the mean weight and height gains with their
standard errors. Weight and height gains were also calculated
separately for children who were underweight, stunted and wasted
at enrolment in both groups. Although in such analyses area-
specific results are affected by regression to the mean, the
comparison of 25 versus 25 areas remains unbiased. All p-values
refer to two-sided significance tests.
Results
A total of 3935 children, aged 1 to 5 years at entry, 1967 from
25 anganwadi centers allocated ‘‘usual care’’ and 1968 from 25
anganwadi centers allocated ‘‘usual care plus albendazole’’ were
enrolled in the study from April to August, 1994 and followed up
until December, 1996 (Figure 1). Relative to WHO reference
standards, the point prevalence at baseline of underweight was
49% (1924 children), stunting 63% (2471), and wasting 18% (699).
The children were all from families with incomes below the
national poverty level, and 51% were girls. The children were
treated and surveyed 5 times (at 0, 6, 12, 18 and 24 months) and
anthropometric data were collected on all 5 occasions from 95%
(3712/3912) of the surviving children in each arm of the study. At
24 months, 99% (3855/3912) of the surviving children were
measured. There were 23 deaths in 2 years, of which 13 were in
Figure 1. CONSORT Flow Chart
doi:10.1371/journal.pntd.0000223.g001
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plus albendazole.
At the 1 year follow up there was no significant difference in
height gain (7.5 [SE 0.3] cm vs. 7.6 [SE 0.2] cm), but the usual care
plus albendazole arm had gained significantly more weight (1.57
[SE 0.06] kg vs. 1.93 [SE 0.08] kg, difference 0.36 [SE 0.10] kg,
p=0.0007). At 2 years the albendazole group showed slightly
greater height gain (13.4 cm vs. 14.1 cm, difference 0.7 [SE 0.4]
cm, p=0.11) but this difference was still not significant. The usual
care plus albendazole arm continued, however, to show a highly
significant difference in weight gain (2.8 [SE 0.1] kg vs. 3.8 [SE 0.1]
kg, difference 1.0 [SE 0.15] kg, p=10
211), with the dewormed
children exhibiting a 35 (SE 5) % higher weight gain. This is
equivalent to an additional 1.0 (SE 0.15) kg over 2 years (99% CI:
0.6–1.4 kg). For the 2-year gains in height and weight the intra-
cluster correlation coefficients were not zero (0.11 for height gain
[95% CI 0.07–0.15]; 0.17 for weight gain [95% CI 0.11–0.23]: see
Methods). The SE calculations allow for this, however, as they are
based only on the 50 area-specific mean gains.
The mean heights in the two arms at each visit are shown in
Figure 2, with all mean values and standard errors calculated only
from the 50 (25 vs 25) area-specific mean results. The usual care
plus albendazole arm children were, by chance, slightly taller at
entry (1.2 [SE 0.6] cm, p=0.06), and this difference in mean
height persisted throughout the study. Figure 3 shows the
corresponding results for weight. The usual care plus albendazole
arm children had, by chance, slightly lower mean weight at entry
(0.3 [SE 0.2] kg, p=0.19), but as the study progressed this was
reversed by the significantly greater weight gain.
The non-significant differences in height and weight at baseline
pointed in opposite directions before any treatment had been given.
If, as a data-dependent response to these unexpectedly opposite
differences, we were to compare baseline weight-for-height, the
difference would be significant (p=0.0013). We regard this, however,
after much investigation of the originalrecords, as merely anoddity of
the randomization rather than a failure of it, and its effects are
appropriately allowed for in the main analysis by our emphasis on
mean changes from baseline over the 2-year study period.
We compared the scale of the age-specific weight gain in the
usual care arm with the differences in weight between age classes
at baseline (Table 1). The observed weight gain in the study was
similar to the differences in weight between year classes at the
beginning of the study. The growth rate, by both measures,
declines with age, as expected. When these data are compared
with the weight gains in the usual care plus albendazole arm, there
was a significant increase in weight with treatment for all age
classes. This indicates some growth benefit even in the younger
children who are likely to harbour lower worm burdens.
Table 2 shows that for all children, irrespective of treatment
group, the weight gain at 2 years was greater for those children
who were malnourished initially. This effect was significant for
underweight and wasting, but not for stunting. It is, however,
difficult to correct this observation for the effects of measurement
error. One way of doing so is to note that the 2-year weight gain is
also significantly correlated with the weight at the mid-year. For all
nutritional categories, the weight gain was significantly greater for
those children who received albendazole in addition to usual care.
In the under-nourished categories, the greatest gain in weight was
for wasted children and the least for stunted children.
Discussion
These results suggest that, at the time of the study (mid 1990s), 6
monthly deworming as a part of an ICDS program in these urban
Figure 2. Mean Heights by Visit and Treatment
doi:10.1371/journal.pntd.0000223.g002
Figure 3. Mean Weights by Visit and Treatment
doi:10.1371/journal.pntd.0000223.g003
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malnourished pre-school children. The mechanism for this gain
was not assessed by the present study design as we have no
measure of faecal worm egg counts, but it may reflect a direct
effect of deworming on nutrition. The effect may also be indirect
since a negative association between ascariasis and vitamin A
absorption has been described [18], but a study in an area of low
infection prevalence showed a benefit of vitamin A supplementa-
tion that was not further enhanced by deworming [19].
A moderate increase in weight but not height appears to be a
consistent phenomenon in deworming trials of worm-affected
populations. Of five published randomized trials of anthelmintic
treatment that showed significantly increased growth in preschool
children [4,14,20], all reported benefits in ponderal growth, and
only one an increase in linear growth. The lack of a significant
height gain may reflect an initial increase in tissue mass rather
than linear growth for such disadvantaged children; in the children
in Lucknow the height gain was greatest for those stunted initially,
and least for those wasted (data not shown). The results of the
present study are also of similar scale to previous trials where the
annual gain is typically in the range 5% to 10% above the control
group [4,14,20]. The gain observed in the present study was
equivalent to an additional 1.0 (SE 0.15) kg over 2 years, and even
the lower 99% confidence limit of 0.6 kg represents an additional
gain of 0.3 kg per year. Since the size of the populations living in
urban slums is increasing world wide, these findings could be of
growing relevance to middle and low income countries [21].
Inpre-schoolchildrenthereisa directcorrelationbetween weight
and relative risk of death. In 8 prospective studies of children 6 to
59 months of age, set in Asia and Africa, the mean relative risk of
death from common childhood diseases is 8.4 (SE 2.1) with severe,
4.6 (SE 0.9) with moderate and 2.5 (SE 0.3) for mild malnutrition
(where severe malnutrition is weight-for-age z-score ,23, moder-
ate is between 23 and 22 and mild is between 22a n d21) [22] .
However, 80% of deaths in children under five years of age occur in
those that are only mildly malnourished [22] . In India in particular
a high proportion of mortality in children aged 1–5 years old may
be attributed to the potentiating effects of malnutrition on infectious
disease [22]. In the present study the scale of weightgain that canbe
achieved in poor urban settings in India might be sufficient to
contribute to reduced mortality, although a very large study would
be needed to demonstrate this directly.
This study suggests that deworming tablets which costs less than
US$ 0.10 per annum, and can be delivered through the existing
Table 1. Age-specific changes in weight (kg).
Initial age
(years) Initial weight (mean6SE)
Difference in initial
weight per year of age Two-year weight gain during the study (mean6SE)
Usual Care Albendazole Difference
1–1.99 8.8260.15 3.2460.11 4.4160.14 1.1760.18
1.62
2–2.99 10.4460.14 2.9360.11 4.0460.14 1.1160.18
1.30
3–3.99 11.7460.14 2.7060.09 3.8360.15 1.1360.17
1.50
4–4.99 13.2460.11 2.4560.12 3.3360.13 0.8860.18
*Each mean value is an average of one value per slum area, and its standard error (SE) reflects this appropriately.
doi:10.1371/journal.pntd.0000223.t001
Table 2. Weight gain (kg) over two years, usual care versus albendazole, stratified by nutritional status at baseline.
Status at baseline Usual Care Mean gain6SE Albendazole Mean gain6SE p value (A vs. UC)
(UC) (A)
a. Underweight* 3.2360.09 (800) 4.2760.11 (1016) ,0.00001
b. Not underweight 2.4260.09 (1060) 3.1560.11 (836) ,0.00001
p value, a vs. b ,0.00001 ,0.00001
c. Stunted* 2.8060.10 (1215) 3.8560.13 (1122) ,0.00001
d. Not stunted 2.7660.09 (645) 3.6060.13 (730) ,0.00001
p value, c vs. d 0.30 0.16
e. Wasted* 3.6360.11 (247) 4.5660.12 (400) ,0.00001
f. Not wasted 2.6560.08 (1613) 3.5660.11 (1452) ,0.00001
p value, e vs. f ,0.00001 ,0.00001
ALL 2.7860.09 (1860) 3.7660.12 (1852) ,0.00001
All means and standard errors in the table are derived appropriately from the 50 slum area means, as befits the cluster-randomization scheme. Numbers of children are
given in brackets.
*More than 2 standard deviations below WHO nutritional standards (given sex) for weight-for-age, height-for-age and weight-for-height.
doi:10.1371/journal.pntd.0000223.t002
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and, perhaps, survival in urban north India.
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